Sarraju A, Brennan D, Hayden K, Stronczek A, et al. Fixed-dose combination of obicetrapib and ezetimibe for LDL cholesterol reduction (TANDEM): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet 2025;405:1757-1768.
PMID: 40347969